PulmoBioMed Ltd.

PulmoBiomed is a biotechnology startup based in the United Kingdom, founded in 2020. The company's slogan, "Your Breath, Your Health," reflects its focus on commercializing state-of-the-art exhaled breath condensate & aerosol sampling technology for disease and environmental diagnostics.

Their lead product, PBM-HALE, is a passive fluid aerosol sampler designed to segregate exhaled and environmental particles by size, addressing key issues such as sample contamination, loss prevention, and ensuring highly reproducible data with digital molecular precision. This technology has demonstrated utility in biological agent capture, genomic/microbiomic analytics, and metabolomic profiling, offering a one-stop solution.

PulmoBioMed's vision is to develop the first hand-held biomolecular analyzer for medical, veterinary, well-being, and environmental use, while their mission is to deliver molecular diagnostic-grade health data from lips to hand.

The company, a Northumbria University spinout, has received support from the Northern Accelerator, iCURe, and InnovateUK. Their most recent milestone includes securing a £700.00K Seed Round investment on 08 February 2024, with backers including the European Innovation Council, SFC Capital, Northumbria University, and the Northeast Venture Fund (NEVF).